Related Experiment Video
Updated: Jan 9, 2026

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury
Published on: May 21, 2018
Inhalable Exosomes in Respiratory Therapies with the Transformative Potential
Jinming Gou1, Lina Zhang2, Guowei Wang3
1Department of General Practice, Troops of the People's Liberation Army, Urumqi, Xinjiang, 830009, People's Republic of China.
Inhaled exosomes show promise for treating lung diseases by leveraging their natural intercellular communication abilities. This targeted delivery enhances therapeutic efficacy while minimizing side effects for respiratory conditions.
Area of Science:
- Nanomedicine
- Cell Biology
- Pulmonology
Background:
- Exosomes are nanoscale vesicles crucial for intercellular communication, immune regulation, and tissue repair.
- Inhalable formulations enhance exosome potential for targeted respiratory delivery, minimizing systemic side effects.
Purpose of the Study:
- To provide a comprehensive review of exosome biology, pulmonary delivery, and therapeutic applications in respiratory diseases.
- To highlight the immunomodulatory and anti-aging properties of exosomes.
- To discuss challenges and future prospects for inhaled exosome therapy.
Main Methods:
- Review of fundamental exosome biology, biogenesis, and cargo.
- Analysis of preclinical and clinical studies on inhaled exosome efficacy.
- Discussion of nanotechnology and personalized medicine approaches.
Main Results:
- Inhaled exosomes demonstrate efficacy in treating acute lung injury, ARDS, COPD, pulmonary fibrosis, and lung cancer.
- Exosomes possess immunomodulatory effects, including macrophage polarization and cytokine storm alleviation.
- Exosomes show potential for mitochondrial restoration and anti-aging benefits.
Conclusions:
- Local pulmonary delivery of exosomes offers enhanced bioavailability and reduced systemic exposure.
- Engineering exosomes with tailored payloads and specificity holds transformative potential for respiratory and systemic therapies.
- Overcoming challenges in production and regulation is key to realizing the clinical potential of inhaled exosomes.
More Related Videos
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
09:18Isolation of Extracellular Vesicles from Murine Bronchoalveolar Lavage Fluid Using an Ultrafiltration Centrifugation Technique
Published on: November 9, 2018
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Inhaled Medications
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Breathing
Pulmonary Cycle: Exhalation
Microorganisms in Medicine and Therapeutics